Comorbidities, Coinfections, & Complications
Active Resources: 23
Webinar Recordings
-
5/7/2020
-
6/20/2019
-
11/15/2018
-
11/8/2018
-
3/21/2018
Toolkits
-
4/3/2020
-
3/20/2020 (reviewed: 6/29/2020)
-
2/28/2020
-
6/2/2015 (reviewed: 5/17/2019)
OIs & Complications Guidelines
-
3/18/2019 (reviewed: 2/11/2020)
-
2/8/2019
Online and Self-Paced Learning
-
2/5/2019 (reviewed: 9/19/2020)
-
11/16/2016
-
10/19/2016
-
10/12/2016
Patient Information
-
5/31/2018 (reviewed: 11/29/2019)
Online Training
-
10/20/2017
Slide Sets
-
9/15/2017
Articles & Bibliographies
-
8/1/2017
Self-Study Materials
-
2/1/2017
Reports
-
1/1/2017
Manuals
-
10/25/2016
Primary Care Guidelines
-
11/9/2015
Archive Resources: 8
Online and Self-Paced Learning
-
12/7/2016
-
10/26/2016
Reports
-
8/27/2015
Webinar Recordings
-
4/7/2015 (reviewed: 5/8/2019)
-
3/3/2015 (reviewed: 5/8/2019)
-
12/11/2014 (reviewed: 5/8/2019)
-
9/4/2014 (reviewed: 5/8/2019)
Image Library
-
1/31/2014
Articles: 2
-
HIV and Heart Disease – NIH Explores the Connection
HIV-positive men and women can now live longer than ever before. A 2013 study found that a newly diagnosed 20 year old on effective antiretroviral therapy (ART) can expect to live into their 70s. A lifespan only slightly lower than in people without HIV.[1] While this is great news, physicians...
-
Use of Dolutegravir in Dialysis
Dolutegravir has several characteristics that, in theory, suggest it will not be significantly removed by dialysis: It has a large apparent volume of distribution (17.4 L) and is highly protein bound (98.9%). A small study of 5 HIV-infected patients with end-stage renal disease undergoing...
-
Sep 23
-
Sep 23
-
Sep 30
-
Nov 11ANAC2020 Virtual ConferenceEvent type: Conferences & Events
-
Jul 25